Skip to content

13F-HR filed by Apis Capital Advisors, LLC

Apis Capital Advisors, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 26 holding rows worth $74,601,000.

Accession
0001420506-19-000212
Filed
2019-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 26 entries on the cover page, a total value of $74,601,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $74,601,000 with VALUE read as thousands by filing date, 13F file number 028-13123. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMARIN CORP PLC023111206SPONS ADR NEW1,162,000$15,815,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock490,000$6,983,000thousands by filing date
GOLAR LNG LTDG9456A100SHS314,000$6,833,000thousands by filing date
ZOGENIX INC.98978L204Common Stock153,500$5,597,000thousands by filing date
CYBEROPTICS CORP COM232517102Stock220,000$3,879,000thousands by filing date
VICOR CORP925815102COM100,000$3,779,000thousands by filing date
KEMET CORP488360207COM NEW210,000$3,683,000thousands by filing date
INTELSAT S AL5140P101COM170,000$3,636,000thousands by filing date
SILICON MOTION TECHNOLOGY CORP SPONSORED ADR82706C108ADR105,000$3,623,000thousands by filing date
GREEN DOT CORP CLASS A39304D102CL A40,000$3,181,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS81,100$2,715,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM40,000$2,424,000thousands by filing date
MATCH GROUP INC57665R106COM35,000$1,497,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM12,000$1,310,000thousands by filing date
VERISK ANALYTICS INC COM92345Y106Stock12,000$1,308,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM160,000$1,259,000thousands by filing date
DSP GROUP INC23332B106COM100,000$1,120,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM27,000$1,108,000thousands by filing date
CONTURA ENERGY INC21241B100COM16,000$1,052,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM120,000$918,000thousands by filing date
ELECTRO SCIENTIFIC INDS285229100COM30,000$899,000thousands by filing date
BOVIE MEDICAL CORP10211F100COM100,000$648,000thousands by filing date
LIQTECH INTERNATIONAL53632a102COM446,000$611,000thousands by filing date
TOCAGEN INC888846102COM50,000$411,000thousands by filing date
CAS MED SYS INC124769209COM110,000$176,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW10,000$136,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-19-000212this filing2019-02-14acceptance time not in the bulk data set